Dual pricing complaint likely to result in ‘significant market change’


The super complaint over dual pricing is likely to result in “serious and profound” change in the insurance market, analysts believe.

The Citizens Advice complaint, which cuts across all market sectors, has triggered a more detailed investigation into dual pricing in insurance by the Financial Conduct Authority.

Gary Dixon, the chairman of the Association of Independent Non-Executive Directors, said super complaints were not brought “wily-nilly”.

“They research long and hard to ensure that their cases are ironclad and will result in significant insurance market change,” said Dixon.

“If I was on the board of an insurer, I would see this as a warning beacon prompting me to look very carefully at how my firm’s policies and working practices may stand up to the harsh spotlight of external criticism as there will be plenty on the way.”

He pointed to the widespread fallout from payment protection insurance, which was raised originally as a super complaint.

Dixon added: “My advice to the chair of any board in the insurance sector is to look very, very carefully at the policies driven by the board and the composition of the board itself.

“Does the board contain someone sufficiently independent to stand up for the rights of the consumers and ensure that changes are made? After all, any such changes now should help avoid the potential downsides of future compensation and redress.”

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: